IFP Advisors Inc Purchases 428 Shares of The Clorox Company $CLX

IFP Advisors Inc boosted its position in shares of The Clorox Company (NYSE:CLX) by 8.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,289 shares of the company’s stock after purchasing an additional 428 shares during the period. IFP Advisors Inc’s holdings in Clorox were worth $635,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Hsbc Holdings PLC grew its holdings in shares of Clorox by 118.8% in the 1st quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock valued at $159,699,000 after acquiring an additional 589,544 shares in the last quarter. Robeco Institutional Asset Management B.V. grew its holdings in shares of Clorox by 101.8% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 1,083,723 shares of the company’s stock valued at $130,123,000 after acquiring an additional 546,761 shares in the last quarter. KBC Group NV grew its holdings in shares of Clorox by 688.7% in the 1st quarter. KBC Group NV now owns 587,679 shares of the company’s stock valued at $86,535,000 after acquiring an additional 513,171 shares in the last quarter. AQR Capital Management LLC grew its holdings in shares of Clorox by 412.1% in the 1st quarter. AQR Capital Management LLC now owns 598,758 shares of the company’s stock valued at $88,167,000 after acquiring an additional 481,846 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Clorox by 147.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company’s stock valued at $104,107,000 after acquiring an additional 421,453 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.3%

Shares of NYSE:CLX opened at $120.51 on Tuesday. The company has a 50-day simple moving average of $122.14 and a 200 day simple moving average of $128.40. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company has a market capitalization of $14.67 billion, a P/E ratio of 18.48, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period last year, the business posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.1%. Clorox’s dividend payout ratio (DPR) is 76.07%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on CLX shares. JPMorgan Chase & Co. decreased their price objective on Clorox from $135.00 to $127.00 and set a “neutral” rating for the company in a report on Friday. Wells Fargo & Company decreased their price objective on Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a report on Thursday, September 25th. TD Cowen decreased their price objective on Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a report on Wednesday, October 1st. Citigroup decreased their price objective on Clorox from $135.00 to $130.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. Finally, Bank of America cut their target price on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, Clorox currently has an average rating of “Reduce” and a consensus target price of $131.64.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.63% of the stock is owned by company insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.